For informational purposes only — not investment advice

← Back to signals

HLF

HERBALIFE LTD.

Research: Finviz ↗·Perplexity ↗

No convergence signal this quarter — shown because tracked funds have filed 13D/G on this stock.

Days to cover (short int.)
5.2d↓-8.1%
as of 2026-10-30 · shares short vs 2026-09-30

News Summary

Neutral

Herbalife delivered Q3 2026 earnings that beat expectations with 6.0% net sales growth (fifth consecutive quarter of expansion) and announced a $250M share repurchase program, but the CEO transition—with founder-era CEO Stephan Gratziani exiting effective October 31, 2026, and CFO John DeSimone assuming interim CEO role—introduces near-term leadership uncertainty during a period of operational momentum.

Red flags

  • •CEO departure effective October 31, 2026, with interim CFO replacement creating leadership vacuum
  • •Zacks downgrade from 'strong-buy' to 'hold' in late October, indicating analyst skepticism despite earnings beat
  • •Interim CEO arrangement suggests search for permanent replacement may be ongoing, creating extended uncertainty

Fund 13D/13G Filings (1)

Tracked funds' beneficial-ownership filings on this stock — disclosed within days of a position change, fresher than the quarterly 13F. Since Filing compares the stock to SPY from the filing date (shown for filings within the last 90 days).

FundForm∆ Shares% of ClassSince FilingFiledSrc
Baupost GroupSC 13G/A—9.8%
+2.7% vs SPY
-2.4% abs
2026-11-13↗